Crescent Energy is the week's most interesting E&P story: short sellers are cutting positions fast, options traders have turned sharply more defensive, and analysts are raising targets — all while the stock has already moved 20% in a single month.
The positioning data tells a story of shorts in retreat. Short interest has dropped almost 16% over the past week, falling from roughly 43.5 million shares to 36.3 million, and is down nearly 20% over the past month. At 14.3% of the free float, short interest remains elevated in absolute terms — this is not a lightly shorted name — but the direction of travel is clearly against the bears. The borrow market is relaxed: availability is running at roughly 773% of short interest, well above the 52-week trough of around 225%, and cost to borrow is a negligible 0.45%. Those numbers describe a lending pool with plenty of slack. There is no mechanical squeeze pressure here; shorts are exiting on their own terms as the stock climbs.
Options, however, are telling a different story. The put/call ratio jumped to 0.30 on August 18 — nearly 60% above its 20-day average of 0.19, and 3.6 standard deviations from that mean, the highest z-score reading in the data series. That is a sharp and sudden demand for downside protection from a market that has been uniformly call-heavy for months. The ratio had been flat near 0.18 for most of July and early August; the acceleration in the last two sessions stands out. Bulls buying the rally are also hedging it.
The Street has moved constructively, though not uniformly. Wells Fargo was the most aggressive mover this month, lifting its target from $18 to $24 while maintaining Overweight — a 33% target increase that is the highest price target among recent changes and well above the current $12.95. UBS followed with a modest bump to $14, and Mizuho and Stephens both raised targets while staying on the sidelines or positive. The mean target across the coverage universe is $16.73, implying roughly 29% upside from here. Valuation remains undemanding: P/E of 5.5x and EV/EBITDA near 3.4x, both at or near multi-month lows after slipping over the past 30 days. The ORTEX factor scores add nuance — EPS surprise ranks in the 85th percentile of the universe, and the forward earnings growth score is near the top of the entire market, but the short-score rank sits only in the 12th percentile, reflecting how much short interest has historically weighed on this name's positioning metrics.
Institutional ownership is broad and incrementally positive. BlackRock added roughly 1.4 million shares in the most recently reported period, and Dimensional Fund Advisors added more than 3 million. Invesco's reported position jumped by over 6 million shares, the largest addition among top holders. The insider picture is cloudier: a Liberty Mutual Foundation block sale of 32.6 million shares at $12.33 in early May was the dominant event of the past 90 days, contributing to a net insider sale figure of $403 million in the quarter. That was a foundation-level liquidation rather than a signal from operating management, but it added significant supply to the market at the time.
Peer E&P names moved in line with CRGY this week. CHRD gained 3.4% on the week, PR added 4.1%, APA 4.3%, while MTDR and SM led the group with gains above 8-9%. Crescent's 4.3% weekly move kept pace with the mid-tier of the peer group — neither a standout laggard nor a leader, which makes the degree of short covering this week more notable on a relative basis.
The next scheduled earnings event is November 4. Between now and then, the key variables to watch are whether the shorts continue to cover or begin rebuilding, whether the options put/call ratio normalises back toward 0.19 or sustains its elevated level, and how the Wells Fargo $24 target — the most aggressive on the Street — holds up as the stock closes the gap toward mean analyst estimates.
See the live data behind this article on ORTEX.
Open CRGY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
